期刊文献+

少突胶质瘤染色体1p/19q联合缺失与Ki-67表达的关系 被引量:1

Correlation research between loss of chromosome 1p/19q and protein expression of Ki-67 of oligodendrocytes glioma
下载PDF
导出
摘要 目的观察少突胶质细胞瘤1号染色体短臂(1p)和19号染色体长臂(19q)联合杂合性缺失(LOH)与Ki-67蛋白表达的相关性,探索预测少突胶质瘤化疗敏感性的分子标记物。方法少突胶质瘤肿瘤组织标本31例作为实验组,少突胶质瘤瘤旁正常脑组织标本13例作为对照组,免疫组化方法检测两组Ki-67蛋白的表达,荧光原位杂交技术检测1p/19q的缺失情况。结果对照组有1例Ki-67表达呈现阳性(7.7%),实验组有14例Ki-67表达呈现阳性(45.0%),两组阳性率差异有统计学意义(P<0.05);对照组无1p/19q缺失,实验组有13例(41.9%)1p/19q联合缺失,其中1p单独缺失2例(6.4%),19q单独缺失1例(3.2%)。Ki-67蛋白表达与1p/19q联合缺失显著相关(r=0.403,P<0.05)。结论 Ki-67蛋白表达是预测少突胶质瘤化疗敏感性的潜在分子标记物。 Objective To observe oligodendrocytes gliomas chromosome 1p/19q deletion and Ki-67 protein expression,explore new molecular markers forecasting chemosensitivity of oligodendrocytes glioma. Methods 31 oligodendrocytes glioma specimens as the experimental group, 13 cases adjacent normal brain tissue of oligodend'rocytes glioma as a control group, the Ki-67 protein detec- ted by immunohistochemistry and lp/19q detection detected by fluorescence in situ hybridization. Results Compared with control group,the experimental group had 14 cases of Ki-67 expression with positive rate 45%;lp/19q deletions was not detected in the control group, 1 p/19q loss for 13 cases(41.9 %) in the experimental group of 31 cases of oligodendroglioma glioma specimens, lp a- lone missing for 2 cases(6.4%),19q alone missing for 1 case(3.2%). Ki-67 protein expression and the lp/19q loss was significant correlation(P〈0.05). Conclusion Ki-67 protein expression in the gliomas may be as the potential molecular markers of chemosen- sitivity oligodendrocytes gliomas.
出处 《重庆医学》 CAS CSCD 北大核心 2013年第20期2347-2348,2351,共3页 Chongqing medicine
关键词 少突胶质瘤 LP 19q KI-67 相关性 oligodendrocytes glioma lp/19q Ki-67 correlation
  • 相关文献

参考文献15

二级参考文献107

  • 1何杰,郑声琴,乔颖娟,姚青,郭庆明,魏晓莹,黄培林.少突胶质细胞肿瘤染色体1p、19q和10q杂合性缺失与临床预后的关系[J].临床与实验病理学杂志,2006,22(4):444-448. 被引量:10
  • 2袁庆国,松本健一,岩城澈.MGMT和Ki-67在胶质母细胞瘤中的表达对ACNU化疗预后的影响[J].中国神经肿瘤杂志,2006,4(3):200-204. 被引量:4
  • 3张淑坤,卢德宏,朴月善,蔡彦宁,徐庆中.即时荧光定量PCR微卫星分析技术检测少突胶质细胞肿瘤染色体1p/19q杂合性缺失[J].中华病理学杂志,2006,35(12):731-734. 被引量:9
  • 4Richard D,Kaloshi G,Amiel-Benouaich A,et al.Dynamic history of low-grade gliomas before and after temozolomide treatment.Ann Neural,2007,61:484-490.
  • 5Bouvier C,Roll P,Quilichini B,et al.Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH:usefulness for stereotactic biopsies.J Neurooncol,2004,68:141-149.
  • 6Weller M,Berger H,Hartmann C,et al.Combined 1p/19q loss in oligodendroglial tumors:predictive or progrtostic biomarker?Clin Cancer Res,2007,13:6933-6937.
  • 7Central nervous system cancers,NCCN clinical practice guidelines in oncology,2010,v.1:9-10.
  • 8Nagasaka T,Gunji M,Hosokai N,et al.FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.Brain Tumor Pathol,2007,24:1-5.
  • 9Louis DN,Ohgaki H,Wiestler OD,et al.The 2007 WHO classification of tumours of the central nervous system.Acta Neuropathol,2007,114:97-109.
  • 10Cairncross JG,Ueki K,Zlatescu MC,et al.Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.J Natl Cancer Inst,1998,90:1473-1479.

共引文献36

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部